Literature DB >> 21461690

Comment on: Use of MR Venography for Characterization of the Extracranial Venous System in Patients with Multiple Sclerosis and Healthy Control Subjects : Zivadinov R, Lopez-Soriano A, Weinstock-Guttman B et al. Radiology. 2011;258:562-70.

Kira Lutz1, Alexander Radbruch, Martin Bendszus.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21461690     DOI： 10.1007/s00062-011-0062-9

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN： 1869-1439            Impact factor:   3.649


× No keyword cloud information.
  12 in total

Review 1.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

2.  Hemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosis. Correlation with symptoms at onset and clinical course.

Authors:  I Bartolomei; F Salvi; R Galeotti; E Salviato; M Alcanterini; E Menegatti; M Mascalchi; P Zamboni
Journal:  Int Angiol       Date:  2010-04       Impact factor: 2.789

3.  Experimental multiple sclerosis vascular shunting procedure halted at Stanford.

Authors: 
Journal:  Ann Neurol       Date:  2010-01       Impact factor: 10.422

4.  Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study.

Authors:  R Zivadinov; C Schirda; M G Dwyer; M E Haacke; B Weinstock-Guttman; E Menegatti; M Heininen-Brown; C Magnano; A M Malagoni; D S Wack; D Hojnacki; C Kennedy; E Carl; N Bergsland; S Hussein; G Poloni; I Bartolomei; F Salvi; P Zamboni
Journal:  Int Angiol       Date:  2010-04       Impact factor: 2.789

5.  Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects.

Authors:  Robert Zivadinov; Alexandra Lopez-Soriano; Bianca Weinstock-Guttman; Claudiu V Schirda; Christopher R Magnano; Kresimir Dolic; Cheryl L Kennedy; Christina L Brooks; Justine A Reuther; Kristin Hunt; Michelle Andrews; Michael G Dwyer; David W Hojnacki
Journal:  Radiology       Date:  2010-12-21       Impact factor: 11.105

6.  No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study.

Authors:  Mike P Wattjes; Bob W van Oosten; Wolter L de Graaf; Alexandra Seewann; Joseph C J Bot; René van den Berg; Bernard M J Uitdehaag; Chris H Polman; Frederik Barkhof
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-27       Impact factor: 10.154

7.  Chronic cerebrospinal venous insufficiency and multiple sclerosis.

Authors:  Omar Khan; Massimo Filippi; Mark S Freedman; Frederik Barkhof; Paula Dore-Duffy; Hans Lassmann; Bruce Trapp; Amit Bar-Or; Imad Zak; Marilyn J Siegel; Robert Lisak
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

8.  No cerebrocervical venous congestion in patients with multiple sclerosis.

Authors:  Florian Doepp; Friedemann Paul; José M Valdueza; Klaus Schmierer; Stephan J Schreiber
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

Review 9.  Anomalous venous blood flow and iron deposition in multiple sclerosis.

Authors:  Ajay Vikram Singh; Paolo Zamboni
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-02       Impact factor: 6.200

10.  Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.

Authors:  P Zamboni; R Galeotti; E Menegatti; A M Malagoni; G Tacconi; S Dall'Ara; I Bartolomei; F Salvi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-12-05       Impact factor: 10.154
View more
  1 in total

1.  Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patients.

Authors:  Bianca Weinstock-Guttman; Robert Zivadinov; Gary Cutter; Miriam Tamaño-Blanco; Karen Marr; Darlene Badgett; Ellen Carl; Makki Elfadil; Cheryl Kennedy; Ralph H B Benedict; Murali Ramanathan
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.